UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Details
Sales, net	$ 12,494	$ 10,390	$ 35,073	$ 32,242
Cost of goods sold	5,115	4,096	13,421	12,042
Gross profit	7,379	6,294	21,652	20,200
Operating expense
Selling, general and administrative	2,878	1,784	8,341	5,433
Research & development	130	108	357	338
Total operating expenses	3,008	1,892	8,698	5,771
Operating income	4,371	4,402	12,954	14,429
Other income (expense)	76	79	196	617
Income before provision for income taxes	4,447	4,481	13,150	15,046
Provision for income taxes	742	(2,281)	2,781	(116)
Net income	$ 3,705	$ 6,762	$ 10,369	$ 15,162
Earnings per common share (basic)	$ 1.00	$ 1.81	$ 2.79	$ 4.07
Earnings per common share (diluted)	$ 0.99	$ 1.80	$ 2.77	$ 4.04
Shares outstanding - basic	3,720	3,733	3,722	3,730
Shares outstanding - diluted	3,737	3,753	3,738	3,752
Other comprehensive income (loss):
Foreign currency translation net of taxes of $0 in all periods	$ (1,683)	$ (385)	$ (1,200)	$ (1,920)
Total comprehensive income	$ 2,022	$ 6,377	$ 9,169	$ 13,242